{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:57:17Z","timestamp":1774641437040,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Significant New Drugs Formulation","award":["2012ZX09501001-004"],"award-info":[{"award-number":["2012ZX09501001-004"]}]},{"name":"Significant New Drugs Formulation","award":["2012ZX09301-002-001-026"],"award-info":[{"award-number":["2012ZX09301-002-001-026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12906-016-1331-6","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T12:25:53Z","timestamp":1473078353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trichloromethane fraction of Incarvillea compacta induces lytic cytotoxicity and apoptosis in Epstein-Barr virus-positive gastric cancer AGS cells"],"prefix":"10.1186","volume":"16","author":[{"given":"Lijing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guibo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"key":"1331_CR1","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.3748\/wjg.v21.i34.9838","volume":"21","author":"M Kanda","year":"2015","unstructured":"Kanda M, Kodera Y. Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol. 2015;21:9838\u201352.","journal-title":"World J Gastroenterol"},{"key":"1331_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S1470-2045(13)70102-5","volume":"14","author":"F Lordick","year":"2013","unstructured":"Lordick F, Kang YK, Chung HC, et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial. Lancet Oncol. 2013;14:490\u20139.","journal-title":"Lancet Oncol"},{"key":"1331_CR3","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1200\/jco.2013.31.15_suppl.4081","volume":"31","author":"N Tebbutt","year":"2013","unstructured":"Tebbutt N, Price TJ, Sjoquist KM, et al. Final results of AGITG ATTAX3 study: Randomized phase II study of weekly docetaxel (T), cisplatin, and fluoropyrimidine (F) with or without panitumumab (P) in advanced esophagogastric (OG) cancer. J Clin Oncol. 2013;31:4081.","journal-title":"J Clin Oncol"},{"key":"1331_CR4","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/bjc.2012.100","volume":"106","author":"JH Yi","year":"2012","unstructured":"Yi JH, Lee J, Lee J, et al. Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum. Brit J Cancer. 2012;106:1469\u201374.","journal-title":"Brit J Cancer"},{"key":"1331_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2559.1999.00686.x","volume":"34","author":"T Kume","year":"1999","unstructured":"Kume T, Shinohara T, Takeo H, Yamashita Y, Shirakusa T, Kikuchi M. Low rate of apoptosis and overexpression of bcl-2 in Epstein\u2013Barr virus-associated gastric carcinoma. Histopathology. 1999;34:7.","journal-title":"Histopathology"},{"key":"1331_CR6","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1038\/onc.2010.203","volume":"29","author":"L Zauner","year":"2010","unstructured":"Zauner L, Melroe GT, Sigrist JA, et al. TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification. Oncogene. 2010;29:4588\u201398.","journal-title":"Oncogene"},{"key":"1331_CR7","first-page":"1920","volume":"62","author":"WH Feng","year":"2002","unstructured":"Feng WH, Israel B, Raab-Traub N, Busson P, Kenney SC. Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. Cancer Res. 2002;62:1920\u20136.","journal-title":"Cancer Res"},{"key":"1331_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/nm.1864","volume":"14","author":"DX Fu","year":"2008","unstructured":"Fu DX, Tanhehco Y, Chen J, et al. Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nat Med. 2008;14:1118\u201322.","journal-title":"Nat Med"},{"key":"1331_CR9","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","volume":"109","author":"SP Perrine","year":"2007","unstructured":"Perrine SP, Hermine O, Small T, et al. A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood. 2007;109:2571\u20138.","journal-title":"Blood"},{"key":"1331_CR10","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2003-03-0930","volume":"103","author":"E Landais","year":"2004","unstructured":"Landais E, Saulquin X, Scotet E, et al. Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1. Blood. 2004;103:1408\u201316.","journal-title":"Blood"},{"key":"1331_CR11","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1158\/0008-5472.CAN-06-1006","volume":"66","author":"WH Feng","year":"2006","unstructured":"Feng WH, Kenney SC. Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression. Cancer Res. 2006;66:8762\u20139.","journal-title":"Cancer Res"},{"key":"1331_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2008.04.025","volume":"589","author":"SF Liu","year":"2008","unstructured":"Liu SF, Wang H, Li ZJ, et al. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells. Eur J Pharmacol. 2008;589:8\u201313.","journal-title":"Eur J Pharmacol"},{"key":"1331_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.canlet.2006.03.022","volume":"247","author":"EJ Jung","year":"2007","unstructured":"Jung EJ, Lee YM, Lee BL, Chang MS, Kim WH. Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. Cancer Lett. 2007;247:77\u201383.","journal-title":"Cancer Lett"},{"key":"1331_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ijc.29698","volume":"138","author":"KF Hui","year":"2016","unstructured":"Hui KF, Cheung AK, Choi CK, et al. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir. Int J Cancer. 2016;138:125\u201336.","journal-title":"Int J Cancer"},{"key":"1331_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jep.2014.08.011","volume":"156","author":"S Zorofchian Moghadamtousi","year":"2014","unstructured":"Zorofchian Moghadamtousi S, Karimian H, Rouhollahi E, Paydar M, Fadaeinasab M, Abdul KH. Annona muricata leaves induce G(1) cell cycle arrest and apoptosis through mitochondria-mediated pathway in human HCT-116 and HT-29 colon cancer cells. J Ethnopharmacol. 2014;156:277\u201389.","journal-title":"J Ethnopharmacol"},{"key":"1331_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/np200906s","volume":"75","author":"DJ Newman","year":"2012","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311\u201335.","journal-title":"J Nat Prod"},{"key":"1331_CR17","volume-title":"Handbook of Tibetan medicine","author":"Y Yang","year":"1991","unstructured":"Yang Y. Handbook of Tibetan medicine. Xining: Qinghai People\u2019s Press; 1991."},{"key":"1331_CR18","first-page":"1799","volume":"34","author":"L Lu","year":"2009","unstructured":"Lu L, Yang M, Lin S, Zheng Q, Zhang W. Chemical constituents from acetyl acetate extract fraction of Incarvillea delavayi. Zhongguo Zhong Yao Za Zhi. 2009;34:1799\u2013801.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1331_CR19","first-page":"1672","volume":"34","author":"Z Huang","year":"2009","unstructured":"Huang Z, Zhang W, Lin S, et al. Chemical constituents from roots of Incarvillea mairei. Zhongguo Zhong Yao Za Zhi. 2009;34:1672\u20135.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1331_CR20","first-page":"1335","volume":"30","author":"ZW Yu","year":"2005","unstructured":"Yu ZW, Zhu HY, Yang XS, Sun QY, Hao XJ. Study on chemical constituents from Incarvillea arguta and their accelerating PC-12 cell differentiation. Zhongguo Zhong Yao Za Zhi. 2005;30:1335\u20138.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1331_CR21","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/14786410802421026","volume":"24","author":"YQ Chen","year":"2010","unstructured":"Chen YQ, Zhang WD, Kong LY, Lu T, Shen YH. Delavayol, a novel sesquiterpene from Incarvillea delavayi Bureau et Franchet. Nat Prod Res. 2010;24:915\u20139.","journal-title":"Nat Prod Res"},{"key":"1331_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s13765-015-0076-0","volume":"58","author":"S Ting","year":"2015","unstructured":"Ting S, Xue L, Wei H, et al. Hepatoprotective effect of phenylethanoid glycosides from Incarvillea compacta against CCl4-induced cytotoxicity in HepG2 cells. J Korean Soc Appl Biol Chem. 2015;58:617\u201325.","journal-title":"J Korean Soc Appl Biol Chem"},{"key":"1331_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.semcancer.2008.12.002","volume":"19","author":"N Susnow","year":"2009","unstructured":"Susnow N, Zeng L, Margineantu D, Hockenbery DM. Bcl-2 family proteins as regulators of oxidative stress. Semin Cancer Biol. 2009;19:42\u20139.","journal-title":"Semin Cancer Biol"},{"key":"1331_CR24","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1590\/S1807-59322007000600017","volume":"62","author":"RN Younes","year":"2007","unstructured":"Younes RN, Varella AD, Suffredii IB. Discovery of new antitumoral and antibacterial drugs from brazilian plant extracts using high throughput screening. Clinics (Sao Paulo). 2007;62:763\u20138.","journal-title":"Clinics (Sao Paulo)"},{"key":"1331_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3724\/SP.J.1009.2012.00048","volume":"10","author":"WG Pan","year":"2012","unstructured":"Pan WG, Jiang SP, Luo P, Gao P, Chen B, Bu HT. Extracts from the roots of Incarvillea younghusbandii on antioxidant effects and life span prolonging in Drosophila melanogaster. Chin J Nat Med. 2012;10:48\u201352.","journal-title":"Chin J Nat Med"},{"key":"1331_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1158\/1940-6207.CAPR-13-0286","volume":"7","author":"Y Lim do","year":"2014","unstructured":"Lim do Y, Lee MH, Shin SH, et al. (+)-2-(1-Hydroxyl-4-oxocyclohexyl) ethyl caffeate suppresses solar UV-induced skin carcinogenesis by targeting PI3K, ERK1\/2, and p38. Cancer Prev Res. 2014;7:856\u201365.","journal-title":"Cancer Prev Res"},{"key":"1331_CR27","doi-asserted-by":"publisher","first-page":"e1002902","DOI":"10.1371\/journal.ppat.1002902","volume":"8","author":"A Woellmer","year":"2012","unstructured":"Woellmer A, Arteaga-Salas JM, Hammerschmidt W. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression. PLoS Pathog. 2012;8:e1002902.","journal-title":"PLoS Pathog"},{"key":"1331_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/B978-0-12-394447-4.30049-9","volume-title":"Encyclopedia of Cell Biology","author":"J Puccini","year":"2016","unstructured":"Puccini J, Kumar S. Caspases. In: Bradshaw RA, Stahl PD, editors. Encyclopedia of Cell Biology. Waltham: Academic; 2016. p. 364\u201373."},{"key":"1331_CR29","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1128\/JVI.70.8.5131-5142.1996","volume":"70","author":"Q Zhang","year":"1996","unstructured":"Zhang Q, Hong Y, Dorsky D, et al. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication. J Virol. 1996;70:5131\u201342.","journal-title":"J Virol"},{"key":"1331_CR30","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1128\/JVI.66.5.2837-2845.1992","volume":"66","author":"FB Furnari","year":"1992","unstructured":"Furnari FB, Adams MD, Pagano JS. Regulation of the Epstein-Barr virus DNA polymerase gene. J Virol. 1992;66:2837\u201345.","journal-title":"J Virol"},{"key":"1331_CR31","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.3390\/v4123420","volume":"4","author":"H Iizasa","year":"2012","unstructured":"Iizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H. Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses. 2012;4:3420\u201339.","journal-title":"Viruses"},{"key":"1331_CR32","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/ijc.24945","volume":"126","author":"KF Hui","year":"2010","unstructured":"Hui KF, Chiang AK. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death. Int J Cancer. 2010;126:2479\u201389.","journal-title":"Int J Cancer"},{"key":"1331_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/carcin\/bgs364","volume":"34","author":"S Liu","year":"2013","unstructured":"Liu S, Li H, Chen L, et al. (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1\/2 and PI3-K\/Akt signaling in EBV-positive cells. Carcinogenesis. 2013;34:627\u201337.","journal-title":"Carcinogenesis"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-016-1331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-016-1331-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-016-1331-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-016-1331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:19:10Z","timestamp":1718777950000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-016-1331-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1186\/s12906-016-1331-6","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,5]]},"article-number":"344"}}